Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/65666
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baune, B. | - |
dc.contributor.author | Hohoff, C. | - |
dc.contributor.author | Roehrs, T. | - |
dc.contributor.author | Deckert, J. | - |
dc.contributor.author | Arolt, V. | - |
dc.contributor.author | Domschke, K. | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Neuroscience Letters, 2008; 436(2):111-115 | - |
dc.identifier.issn | 0304-3940 | - |
dc.identifier.issn | 1872-7972 | - |
dc.identifier.uri | http://hdl.handle.net/2440/65666 | - |
dc.description.abstract | Previous studies on the effects of serotonin receptor 1A (5-HT1A) gene variation on treatment response in depression revealed inconsistent results with studies pointing towards a detrimental influence of the 5-HT1A-1019G allele on antidepressant treatment response, while others did not discern any involvement of 5-HT1A variants. In order to further delineate the impact of 5-HT1A gene variation on pharmacoresponse in depression over 6 weeks of antidepressant treatment, the influence of the 5-HT1A-1019C/G (rs6295) polymorphism was investigated in 340 Caucasian patients with a Major Depressive Episode (DSM-IV) with particular attention to the subtype of depression (major depression and melancholic depression). Antidepressant treatment response across 5-HT1A-1019C/G genotype groups showed no differences in either Major Depressive Episode or major depression between genotype groups, whereas stratification for the melancholic subtype of depression revealed a significantly worse treatment response as conferred by the -1019CC genotype (p=0.02). The poorer treatment response in melancholic depression could first be detected in week 2 (p=0.03), continuing until week 6 and showing a maximum effect in week 3 (p=0.01). The present study adds to the clarification of the role of 5-HT1A variation in treatment response in major depression by providing preliminary support for poor treatment response mediated by the 5-HT1A-1019C allele repressing 5-HT1A activity specifically in the melancholic subtype of depression. | - |
dc.description.statementofresponsibility | B.T. Baune, C. Hohoff, T. Roehrs, J. Deckert, V. Arolt, K. Domschke | - |
dc.language.iso | en | - |
dc.publisher | Elsevier Sci Ireland Ltd | - |
dc.rights | © 2008 Elsevier Ireland Ltd. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.neulet.2008.03.001 | - |
dc.subject | Major Depressive Episode | - |
dc.subject | Melancholic depression | - |
dc.subject | Serotonin receptor | - |
dc.title | Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.neulet.2008.03.001 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Baune, B. [0000-0001-6548-426X] | - |
Appears in Collections: | Aurora harvest 5 Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.